Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>UBS: GALAXY ENT (00027.HK) 3Q EBITDA In Line; Rating Buy Kept w/ $46.9 TP
Recommend 4 Positive 10 Negative 6 |
||||
|
||||
|
GALAXY ENT (00027.HK)'s 3Q25 EBITDA approximated HKD3.3 billion, up 14% YoY and down 6% QoQ, UBS Global Research said in its report. Adjusted for positive VIP hold, EBITDA could be HKD3.3 billion too, meeting both the broker's and market's expectations. By segment, mass GGR elevated 6% QoQ, thanks to the normalization of mass table hold, winning the sector's QoQ growth of about 2-3%. VIP volume grew by approximately 17% QoQ, but VIP GGR sank 15% QoQ on a high base, at VIP hold of around 3.1%. The broker maintained Buy on GALAXY ENT with a target price of HKD46.9. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
